Cdt.northwestern.edu Website Review

THE CENTER FOR DEVELOPMENTAL THERA*EUTICS (CDT) was established to rapidly and efficiently advance novel thera*eutic interventions from basic research to the clinic. The CDT is one of the first academic-based drug development centers that bridges all aspects of translational research in a single entity including early drug discovery, mechanistic research, pre-clinical development and translation into the clinic. Read the rest of our mission here. THE DEVELOPMENTAL THERA*EUTICS CORE (DTC), under the umbrella of CDT, provides services focused on supporting the translation of new thera*eutics to the clinic. See services offered HERE Since its founding, the Center has facilitated the completion of IND-enabling studies for a homegrown, trial-ready drug to treat acute myeloid leukemia, pre-IND, Phase 0 trials for both Au-NP spherical nucleic acids and apoptosis targeting projects, proof-of concept work for the GSK-3β inhibitor 9 ING-41, and the design and characterization of novel peptides that mimic the function of natural DTC works with PI Sui Huang to develop a new compound, metarrestin, to reduce metastasis by human prostate, pacreatic, and breast cancer. diagnostic methods and therapies needed to save lives today. This transdisciplinary convergence of knowledge is creating new fields of research that will have a long-lasting impact on human health and disease.